  World News
 USA (229)
 Bay Area
 San Francisco (1506)
North San Mateo County (149)
South SF (108)
 2008
  Business (18)
 Politics (1)
 Science & Education (3)
 Crime (3)
 Accidents (2)
January
February
March
April
May
June
July
August
September
October
November
December
Genentech
  Real Estate
|
|
|
| Jan.10 |
|
City approved design for ferry terminal Ferry service between Oyster Point and Jack London Square in Oakland could begin by the end of 2009
|
| Jan.14 |
|
4Q Profit Rises 6 Percent The biotech giant barely scraped past expectations as stock dropped in after-hours trading as sales of a key product also fell below expecta...
|
|
| Feb.17 |
|
Prostate cancer vaccine shows promise Shares in Cell Genesys shot up nearly 20% after the company released a favorable analysis of its experimental prostate cancer vaccine GVAX
|
| Feb.22 |
|
FDA Clears Avastin for Breast Cancer| A Genentech drug received federal approval, a surprise decision | |
|
|
| Apr.24 |
|
Court slashes $200 million from judgment The company has been ordered to pay $500 million to a Southern California hospital for failing to pay royalties
|
| |
|
Man Robbed Near ATM  The victim had withdrawn money, when the suspect approached the victim, brandished a black gun and demanded money
|
| Apr.30 |
|
Bad news on cancer drug Rituxan Shares in Genentech sagged, after the company said Rituxan failed to curb symptoms of the debilitating autoimmune disorder
|
|
| Jun.5 |
|
Worker crushed at asphalt plant The death of Tony Ponce, 37, was likely an accident caused when a co-worker inadvertently turned on the machine at the Graniterock plant
|
|
| Jul.21 |
|
Roche Offers $44B For Remaining Shares Roche Holding, which already owns 55.9%, was offering $43.7 billion to take over the remaining shares of Genentech
|
| Jul.25 |
|
Panel to ponder Roche takeover offer Genentech has set up a committee of independent directors to consider Swiss drugmaker offer to acquire all shares it does not already own
|
| Jul.26 |
|
Teen crashes head-on during street race An 18-year-old South San Francisco man is recovering following a head-on crash that happened during a race in the city early morning
|
| Jul.31 |
|
Shareholders sue to halt Roche buyout Shareholders' attorneys are asking a court to invalidate long-standing agreements between Genentech and its majority owner
|
|
| Aug.13 |
|
Genentech rejects Roche's $43.7b bid| Biotechnology giant rejected a buyout offer from its majority owner Roche but said it is open to a higher takeover bid | |
|
| Aug.17 |
|
Recruiters eye Genentech employees While Roche mulls whether to raise its offer price for biotechnology powerhouse, many prized Genentech professionals
|
| Aug.21 |
|
Retention plan to cost $371 million An employee retention plan announced along with its rejection of Roche's buyout offer will cost the biotechnology giant about $371 million
|
| Aug.27 |
|
Cell Genesys Drug Trial Halts| Shares plunged more than 70% after a clinical trial of its cancer vaccine Gvax was stopped due to a higher number of deaths among patients | |
|
|
| Sep.9 |
|
Solazyme producing oil from algae| The startup said that it had produced the world's first algal-derived jet fuel and had passed 11 tests necessary for use in aviation | |
|
| Sep.19 |
|
Fluidigm pushing forward with IPO Fluidigm's intrepid drive to complete its initial public offering during one of the most turbulent weeks in Wall Street history has hit grid...
|
| Sep.25 |
|
Fluidigm Withdraws IPO The small company has ended its effort to go public because the turbulence in the financial markets made it impossible to complete the offering
|
|
| Oct.30 |
|
Homicide Victim Found Map Police found Shivnesh Reddy, 21, suffering from a single gunshot wound. A shooting was possibly the result of an argument over a drug deal
|
|
| Nov.18 |
|
Avastin linked to higher risk of clots| A team of university researchers: Blockbuster cancer drug is linked to a significantly increased risk of blood clots in the veins | |
|
|
| Dec.12 |
|
Bristol-Myers joins Exelixis for drugs Shares in Exelixis Inc. rose nearly 33% on news that major pharmaceutical firm will collaborate on the development of 2 experimental cancer drugs
|
|
|
San Francisco Bay Area
